Literature DB >> 18313832

GDNF-transduced Schwann cell grafts enhance regeneration of erectile nerves.

Florian May1, Kaspar Matiasek, Maurice Vroemen, Christiane Caspers, Thomas Mrva, Christian Arndt, Boris Schlenker, Peter Gais, Thomas Brill, Alexander Buchner, Armin Blesch, Rudolf Hartung, Christian Stief, Bernd Gansbacher, Norbert Weidner.   

Abstract

BACKGROUND: Schwann cell-seeded guidance tubes have been shown to promote cavernous nerve regeneration, and the local delivery of neurotrophic factors may additionally enhance nerve regenerative capacity. The present study evaluates whether the transplantation of GDNF-overexpressing Schwann cells may enhance regeneration of bilaterally transected erectile nerves in rats.
METHODS: Silicon tubes seeded with either GDNF-overexpressing or GFP-expressing Schwann cells were implanted into the gaps between transected cavernous nerve endings. Six (10 study nerves) or 12 wk (20 study nerves) postoperatively, erectile function was evaluated by relaparotomy, electrical nerve stimulation, and intracavernous pressure recording, followed by ultrastructural evaluation of reconstructed nerves employing bright-field and electron microscopy. Additional animals were either sham-operated (positive control; 20 study nerves) or received bilateral nerve transection without nerve reconstruction (negative control; 20 study nerves).
RESULTS: The combination of GDNF delivery and Schwann cell application promoted an intact erectile response in 90% (9 of 10) of grafted nerves after 6 wk and in 95% (19 of 20) after 12 wk, versus 50% (5 of 10) and 80% (16 of 20) of GFP-expressing Schwann cell grafts (p=0.02). The functional recovery was paralleled by enhanced axonal regeneration in GDNF-overexpressing Schwann cell grafts, as indicated by larger cross-sectional areas and a significantly higher percentage of neural tissue compared with GFP-transduced controls.
CONCLUSIONS: These findings demonstrate that the time required to elicit functional recovery of erectile nerves can be reduced by local delivery of GDNF. In terms of clinical application, this enhanced nerve repair might be critical for timely reinnervation of the corpus cavernosum as a prerequisite for functional recovery in men.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18313832     DOI: 10.1016/j.eururo.2008.02.003

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  10 in total

Review 1.  Schwann cells as a therapeutic target for peripheral neuropathies.

Authors:  Helmar C Lehmann; Ahmet Höke
Journal:  CNS Neurol Disord Drug Targets       Date:  2010-12       Impact factor: 4.388

2.  Regeneration of the cavernous nerve by Sonic hedgehog using aligned peptide amphiphile nanofibers.

Authors:  Nicholas L Angeloni; Christopher W Bond; Yi Tang; Daniel A Harrington; Shuming Zhang; Samuel I Stupp; Kevin E McKenna; Carol A Podlasek
Journal:  Biomaterials       Date:  2010-10-23       Impact factor: 12.479

Review 3.  Emerging tools for erectile dysfunction: a role for regenerative medicine.

Authors:  Lukman Hakim; Frank Van der Aa; Trinity J Bivalacqua; Petter Hedlund; Maarten Albersen
Journal:  Nat Rev Urol       Date:  2012-07-24       Impact factor: 14.432

4.  Erectile function restoration after repair of resected cavernous nerves by adipose-derived stem cells combined with autologous vein graft in rats.

Authors:  Chengcheng Ying; Wanli Hu; Bei Cheng; Mei Yang; Xinmin Zheng; Xinghuan Wang
Journal:  Cell Mol Neurobiol       Date:  2014-01-08       Impact factor: 5.046

Review 5.  Stem cell therapy for voiding and erectile dysfunction.

Authors:  Martin Vaegler; Andrew T Lenis; Lisa Daum; Bastian Amend; Arnulf Stenzl; Patricia Toomey; Markus Renninger; Margot S Damaser; Karl-Dietrich Sievert
Journal:  Nat Rev Urol       Date:  2012-06-19       Impact factor: 14.432

Review 6.  Peripheral nerve repair with cultured schwann cells: getting closer to the clinics.

Authors:  Maria Carolina O Rodrigues; Antonio Antunes Rodrigues; Loren E Glover; Julio Voltarelli; Cesario V Borlongan
Journal:  ScientificWorldJournal       Date:  2012-06-04

7.  Low-Intensity Extracorporeal Shock Wave Therapy Enhances Brain-Derived Neurotrophic Factor Expression through PERK/ATF4 Signaling Pathway.

Authors:  Bohan Wang; Hongxiu Ning; Amanda B Reed-Maldonado; Jun Zhou; Yajun Ruan; Tie Zhou; Hsun Shuan Wang; Byung Seok Oh; Lia Banie; Guiting Lin; Tom F Lue
Journal:  Int J Mol Sci       Date:  2017-02-16       Impact factor: 5.923

8.  Recovery of erectile function comparing autologous nerve grafts, unseeded conduits, Schwann-cell-seeded guidance tubes and GDNF-overexpressing Schwann cell grafts.

Authors:  Florian May; Alexander Buchner; Kaspar Matiasek; Boris Schlenker; Christian Stief; Norbert Weidner
Journal:  Dis Model Mech       Date:  2016-11-17       Impact factor: 5.758

9.  Preclinical evidence for the benefits of penile rehabilitation therapy following nerve-sparing radical prostatectomy.

Authors:  M Albersen; S Joniau; H Claes; H Van Poppel
Journal:  Adv Urol       Date:  2008

10.  Sympathetic innervation induced in engrafted engineered cardiomyocyte sheets by glial cell line derived neurotrophic factor in vivo.

Authors:  Xian-ming Fu; Jong-Kook Lee; Keiko Miwa; Tatsuya Shimizu; Yoshiko Takagishi; Masumi Hirabayashi; Kazuhiko Watabe; Akihiko Usui; Itsuo Kodama; Yuichi Ueda
Journal:  Biomed Res Int       Date:  2013-08-28       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.